Skip to main content
. 2022 Dec 30;30(1):545–558. doi: 10.3390/curroncol30010043

Table 3.

Comparison of characteristics between EMVI groups.

Characteristics EMVI − EMVI + p
Age (years), Me (Q1; Q3) 65.90 (58.75; 74.00) 64.90 (59.48; 71.76) 0.667
Sex (female), n (%) 43 (41.0) 30 (38.5) 0.8512
Tumor, n (%)
T2-T3 96 (91.4) 50 (65.8) <0.0012
T4 9 (8.6) 26 (34.2)
Lymph nodes, n (%)
N0 49 (52.7) 19 (26.4) <0.0012
N1 35 (37.6) 28 (38.9)
N2 9 (9.7) 25 (34.7)
Stage, n (%)
II-III A 59 (57.8) 25 (32.9) <0.0012
III B 38 (37.3) 27 (35.5)
III C 5 (4.9) 24 (31.6)
ALC (109/L), Me (Q1; Q3) 1.70 (1.33; 2.24) 1.90 (1.45; 2.26) 0.217
AMC (109/L), Me (Q1; Q3) 0.58 (0.46; 0.80) 0.63 (0.53; 0.75) 0.181
ANC (109/L), Me (Q1; Q3) 4.49 (3.62; 5.81) 5.10 (4.07; 6.16) 0.041
Platelets (109/L), Me (Q1; Q3) 253.50 (217.00; 313.25) 303.00 (249.50; 361.75) 0.001
LMR, Me (Q1; Q3) 2.90 (2.30; 3.83) 2.86 (2.20; 3.79) 0.885
NLR, Me (Q1; Q3) 2.54 (2.05; 3.31) 2.82 (2.18; 3.43) 0.189
PLR, Me (Q1; Q3) 150.70 (115.97; 200.00) 167.19 (119.95; 218.05) 0.293
LMR above median, n (%) 53 (50.0) 38 (48.7) 0.9822
NLR above median, n (%) 49 (46.2) 43 (55.1) 0.2962
PLR above median, n (%) 49 (46.2) 43 (55.1) 0.2962
CEA, Me (Q1; Q3) 3.62 (2.24; 6.97) 5.63 (3.07; 9.68) 0.027
CA19-9, Me (Q1; Q3) 9.87 (5.36; 15.76) 11.71 (2.77; 18.29) 0.741

Bold font indicates statistical significance. EMVI, extramural vascular invasion; ALC, absolute lymphocyte count; AMC, absolute monocyte count; ANC, absolute neutrophil count; LMR, lymphocyte-to-monocyte ratio; NLR, neutrophil-to-monocyte ratio; PLR, platelet-to-lymphocyte ratio; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; Q, quartile; Me, median. Differences in the level of quantitative variables between groups were analysed with Mann–Whitney’s U test, dependencies between qualitative variables and groups were analysed with chi-square test2 (with Yate’s correction for continuity for 2 × 2 tables).